Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2741)
All Articles published online
|
Publishing Process of This Article
|
May 15, 2025 (publication date) through Apr 11, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Lin YT, Tan J, Tao YL, Hu WW, Wang YC, Huang J, Zhou Q, Xiao A. Effect of ranibizumab on diabetic retinopathy via the vascular endothelial growth factor/STAT3/glial fibrillary acidic protein pathway. World J Diabetes 2025; 16(5): 99473 [PMID: 40487605 DOI: 10.4239/wjd.v16.i5.99473] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Lin YT, Tan J, Tao YL, Hu WW, Wang YC, Huang J, Zhou Q, Xiao A. Effect of ranibizumab on diabetic retinopathy via the vascular endothelial growth factor/STAT3/glial fibrillary acidic protein pathway. World J Diabetes 2025; 16(5): 99473 [PMID: 40487605 DOI: 10.4239/wjd.v16.i5.99473] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v16/i5/99473.htm |
| Number | Citing Articles |
| 1 |
Sichen Yang, Guoyan Mo, Xinxin Pi, Tao Xiong, Long Cheng, Yan Meng, Junjie Hu, Weizhong Jiang, Zhaohua Shi. Unraveling the Therapeutic Mechanisms of Shanzhen Mingmu Pill in Diabetic Retinopathy: An Integration of Serum Pharmacochemistry, Network Pharmacology, and Experimental Validation. Phytochemical Analysis 2026; 37(2): 287 doi: 10.1002/pca.70038
|
| 2 |
Sha Liu, Jingjing Hou, Yulin Tao, Yi Xu, Jinghui Liu, Siyu Lin, Liming Tao, Zhengxuan Jiang. ELF3-regulated PES1 targets VEGFR2 to mediate angiogenesis and retinal inner barrier injury in diabetic retinopathy. Journal of Translational Medicine 2025; 23(1) doi: 10.1186/s12967-025-07334-0
|